Dr. Chebib dreamed of finding an alternative to
#dialysis
to treat patients with
#PolycysticKidneyDisease
, like his own father. Now for the first time there’s hope. …ion-to-find-cure/
A special appeal to all
#ProgramDirectors
in this match cycle: Please give thoughtful consideration to
#IMG
applicants from war-torn regions, like the Middle East. The hardships they’ve endured to reach this point are immense, regardless of religion or background.
#MedTwitter
Today marks my father’s birthday!We lost him to
#ADPKD
last year!Today I learned that my
#R01
application aimed to understand
#PKD
in a novel/unbiased approach didn’t get funded. Can’t wait to hear the reviewers feedback!will keep fighting until the cure is reached
@PKDFoundation
Honored and grateful to have given the symposium on
#ADPKD
this year on this prestigious national/international stage!
@ASNKidney
. So much
#hope
&
#innovation
in ADPKD thanks to the strong collaboration between academia, industry,
@PKDFoundation
, and
@US_FDA
! The future is bright
Congratulations to Class
#2020
@MayoClinic
Nephrology and hypertension, kidney transplant and onco-nephrology fellows🎉 You make us proud👏👏 thank you for this humbling gift of choosing me the teacher of the year! It has been an honor working with all of you!
We are so excited and proud to share that
@MayoClinic
#Jacksonville
Florida has been designated as Center of Excellence for
#ADPKD
care
@PKDFoundation
We are eager to serve our patients regionally, nationally and internationally in our holistic multidisciplinary
#PKD
clinic
Today is
#PkdAwaresnessDay
On this day and every day, we collectively renew our commitment to accelerate innovation, research, health solutions, treatments & clinical practices that will slow the disease, make living with it tolerable, & eventually CURE it!
@PKDFoundation
It has been such an honor be invited
@CleClinicKidney
@CleClinicMD
grand rounds and have exciting discussions about current and future state of nephrology! I enjoyed the time with the wonderful attendings, fellows and their hospitality.
It is a happy day when your mentee reach an important milestone! Congratulations for our stellar postdoc
@MarounCh3
for
#matching
@HennepinHC
Internal medicine residency program! All your hard work has paid off! Keep shining!
#mentorship
Excited to announce that we are recruiting for a dedicated
#PKD
Translational Research Fellowship
@MayoClinicNeph
JAX
#Florida
! If you are an MD (or equivalent) and looking for a research training program in epidemiology, healthcare delivery, & patient-oriented research- DM me
Today, one of our
#ADPKD
patients rang this 🔔! They just finished getting a new 💊 through
#phase1B
clinical trial! Halting kidney failure is a milestone worth ringing all 🔔🔔! What can we do better to expedite
#cures
?
@ASNKidney
@MedicareGov
@WhiteHouse
Let’s align the ✨✨
Check out our recent publication:
#ADPKD
transplant recipients have the most favorable cardiac profile pretransplantation with better patient survival and MACE-free survival rates as compared with patients with other kidney diseases.
@MayoClinicNeph
The Mayo tri-site PKD centers of Excellence. Excited to work together to bring the care for
#ADPKD
patients to a new level of excellence
@MayoClinic
! We will be meeting regularly for our
#PKD
#board
clinical meeting to discuss challenging cases! Warm welcome to
@ndahl48
!
Do the math! < 60 PKD academic expert to treat > 500,000 patients with ADPKD in the US! We need to join forces! Are you a private practice nephrologist and passionate about seeing
#PKD
patients? Let
@PKDFoundation
know and explore their partner clinic program
We are saddened by the loss of Dr. Textor. An exceptional
@MayoClinicNeph
consultant that embodied the true core values of
@MayoClinic
. You will be greatly missed
I feel extremely lucky to have had Dr. Steve Textor as a mentor. Not only was he an exceptional clinician, educator, and researcher, but he was also a wonderful person. He will be greatly missed…😞
Exciting news for
#ADPKD
“VX-407 is a first-in-class small molecule corrector designed to target the underlying cause of ADPKD in a subset of PKD1 variants, by restoring function to the variant PC1 protein. Vertex plans to initiate a Phase 1 in healthy volunteers this month.”
Moving to the clinic: U.S. FDA clears our Investigational New Drug application for the potential treatment of autosomal dominant polycystic kidney disease (ADPKD). Learn more:
It was a pleasure working on current evidence/definition “PKD diet” with a wonderful group of physicians and scientists passionate about advocating for our
#ADPKD
patients!
@KristenlNowak
@ndahl48
@PKDFoundation
ADPKD is a genetic disorder characterized by kidney cyst formation and progressive kidney function loss. This Review discusses the available evidence supporting the efficacy and safety of dietary interventions in ADPKD
@fouadchebib
@KristenlNowak
@ndahl48
Wonderful
#PKD
community in Tampa, FL! It’s a privilege to take care of such caring and loving PKD families! Great turn out
@PKDFoundation
walk! Looking forward to supporting the Sarasota event soon
Thank you
@PKDFoundation
for your unwavering effort in being the rock in
#ADPKD
journey! And for allowing me to be part of that on the educational advisory panel
Fouad Chebib, M.D. | PKD Foundation Education Advisory Panel via
@YouTube
Clinical Implementation of an Artificial Intelligence Algorithm for Magnetic Resonance–Derived Measurement of Total Kidney Volume
#ADPKD
@MayoClinicNeph
@MCFNephFellows
In
#ADPKD
individuals aged 56–65 years with CKD G3 or G4, compared to a SOC group with mean GFR rate of decline ≥3 ml/min/SA/year, tolvaptan was associated with efficacy similar to that observed in the overall indication.
@MayoClinicNeph
@KidneyMed
I am very excited to share that through this initiate 5 dialysis machines will be sent to Lebanon.
This could not be done without the unconditional generosity of many of you, my friends, colleagues, family, compatriots and philanthropists.
Very happy to participate in the Doctor Q&A for this spring issue of
#PKD
Life magazine! Thank you
@PKDFoundation
for leading the way for finding the cure for
#ADPDK
, one of the most common and devastating inherited diseases🙏🏻
The
#PKD
diet- what is know and safe today! I’m pretty sure this will be updated in the coming years as we anticipate more evidence-based data!
#ADPKD
@MayoClinicNeph
Dietary interventions have recently emerged as potential strategies to induce metabolic reprogramming and slow ADPKD progression. This Review discusses the efficacy and safety of these interventions in ADPKD
@fouadchebib
@KristenlNowak
@ndahl48
Asymptomatic pyuria is associated with kidney failure and faster kidney function decline irrespective of the ADPKD gene and cystic growth.
@MayoClinicNeph
Dr.
@AndrewMallett8
discussing “nomenclature for hereditary kidney diseases : time for a change?”
He also gave a wonderful lecture earlier on underestimated prevalence and burden of monogénisme renal diseases👏👏
Check out this Continuing Medical Education opportunity on Friday, September 8th hosted by one of our Center's of Excellence: "Autosomal Dominant Polycystic Kidney Disease." Reserve your place at
Excited to share our publication on Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges! Check our novel approach in patient inclusion criteria/study design
#ADPKD
@RonPerrone
@PKDFoundation
@US_FDA
@MayoClinic
The KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Polycystic Kidney Disease (
#ADPKD
) is available for public review through Friday, November 17.
You can download the KDIGO ADPKD Guideline Public Review Draft and Data Supplement on
In
#ADPKD
individuals aged 56–65 years with CKD G3 or G4, compared to a SOC group with mean GFR rate of decline ≥3 ml/min/SA/year, tolvaptan was associated with efficacy similar to that observed in the overall indication.
@MayoClinicNeph
@KidneyMed
If you have a BS, MS or PhD in biology and interested in joining my team for a fun adventure in understanding novel mechanisms and drug discovery in
#ADPKD
, please DM me or refer anyone who could be interested.
#job
#science
#discovery
Check out our PIEZO1 work in
#ADPKD
Activating it via Yoda1 reduces significantly cystogenesis in-vitro/ex vivo! However, collecting duct-specific Piezo1 knockout neither induced cystogenesis in WT mice nor affected cystogenesis in Pkd1RC/RC
@BeyderLab
AJKD PERSPECTIVE: Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy
@fouadchebib
@mayoclinic
#ADPKD
Congrats to my colleague
@fervenzafernan1
for receiving the highest Mayo Clinic recognition of Distinguished Clinician at the 2023 annual staff meeting
Consider OFD1 in patients with renal cystic disease that looks exactly like ADPKD : in females with NO family history and cleft palate or any facial or digital malformation and possible cognitive impairment.
In honor of PKD Awareness Day, we’re excited to share this special 'Ask Me Anything' session featuring
@fouadchebib
and
@Vishal_D_Patel
. Watch the full recording to gain insight into many topics that impact the PKD community.
Dr. Aliza Thompson
@US_FDA
brings a critical point to move the field forward: “ will we as a community continue to come together and SHARE data to advance drug development?
#consortia
#KidneyWk
I am saddened by the news coming from
#Lebanon
about bombings, death, and destruction. May the international community make every effort to stop this terrible escalation. It is unacceptable. I express my solidarity with the Lebanese people, who have already suffered too much.
I am thankful for all friends and colleagues who donated to provide these life saving CCRRT machines. The humanitarian needs for chronic and acute kidney disease care in
#Lebanon
will continue to increase due to the collapsed economic state!
@firassabiad
ADPKD has phenotypic variability only partially explained by established biomarkers that do not readily assess factors of inflammation and kidney fibrosis. This study evaluates asymptomatic pyuria as a biomarker for disease progression
@fouadchebib
32a) Do you have trouble convincing your radiology department to measure the TKV for you? Here is a way you can do this in your office through the ellipsoid equation. If unable to obtain sagittal length, substitute with coronal length.
#empower
#nephrologist
(Part 1 of video)
Recently the Phase 3 clinical trial, FALCON was terminated. FALCON was a study evaluating the effectiveness and safety of bardoxolone methyl in patients with ADPKD. So why was the study terminated early? Read all about it on today's blog:
When I visit home during medical school, I used to enjoy dreaming and executing these window designs at my father’s shop! I now realize how much I miss this hobby! What hobby do you miss?
Thank you very much
@PkdResearch
for this great opportunity! Striving all together towards the utmost goal of curing
#ADPKD
It is through such consortiums and collaborations that our patients will hopefully be kidney failure-free in the future
@MayoClinicNeph
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 is happening February 16 - February 18. Great opportunity to update on general Nephrology and Transplantation!
#MayoClinicKidney
Mayo has developed a test to detect
#COVID19
. A process that usually takes 6 months to a year was accomplished in under a month, thanks to a dedicated team working around the clock. Learn more about the Clinical
#Virology
Laboratory
@mayocliniclabs
.
#Dialysis
is different in countries like
#Lebanon
🇱🇧 when sessions are interrupted/shortened due to machine malfunction! Very grateful for everyone who donated for this campaign! 2
#hemodialysis
installed in
#Zahleh
; 3 CRRT will be installed in Sept
#beirut
Yesterday, my friend, colleague and fellow
@BookBurton
podcaster Anna Gaddy (
@AnnaGaddy
) became an altruistic kidney donor! She is home already and her donated kidney is working and just saved someone's life. Go Anna!
#WalkTheWalk